van Bentum, J. S.
Sijbrandij, M.
Kerkhof, A. J. F. M.
Huisman, A.
Arntz, A. R.
Holmes, E. A.
Franx, G.
Mokkenstorm, J.
Huibers, M. J. H.
Funding for this research was provided by:
ZonMw
Article History
Received: 28 March 2019
Accepted: 26 April 2019
First Online: 9 May 2019
Ethics approval and consent to participate
: The Medical Ethics Committee (METc) of the VU medical center (VUmc) approved the initial study protocol (registration number 2017.237). After we conducted a small pilot study to establish safety and feasibility of the intervention, Amendment 4 was approved by the METc VUmc (registration A2017.415) on 18 October 2018. The study is registered at the Netherlands Trial Register, part of the Dutch Cochrane Centre (NTR7563).Patients will be approached by a researcher after they have given oral consent. The purpose of the study is explained and they receive a detailed information brochure. After one week they are asked if they want to participate in the study and provide oral and written consent. The participants will be informed that they may withdraw their consent at any time and that this does not affect their position as health care clients.
: Not applicable. Details, images, or videos relating to individual participants will not be published.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.